|
|||||
|
|
Vitamin D‐related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C |
|
| Authors: | Taeang Arai Masanori Atsukawa Akihito Tsubota Chisa Kondo Noritomo Shimada Hiroshi Abe Norio Itokawa Ai Nakagawa Tomomi Okubo Yoshio Aizawa Katsuhiko Iwakiri |
| Affiliation: | 1. Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan;2. Core Research Facilities for Basic Science, Research Center for Medical Sciences, Jikei University School of Medicine, Tokyo, Japan;3. Division of Gastroenterology and Hepatology, Chiba Tokushukai Hospital, Chiba, Japan;4. Division of Gastroenterology and Hepatology, Jikei University School of Medicine Katsusika Medical Center, Tokyo, Japan |
| Abstract: | |
| Keywords: | vitamin D‐related gene polymorphisms chronic hepatitis C pegylated interferon/ribavirin protease inhibitor 25(OH) D3 level |